Mexico Remains A Challenging Market For Innovative Drugmakers
Pharma & Healthcare / Mexico / Wed 25 Jul, 2018
Key View:
- Mexico remains a key medicine market in Latin America.
- Ageing population and a rising chronic disease burden continues to fuel opportunities for drugmakers.
- Weak regulatory environment and cost-containment measures threaten innovative drugmakers.
Forecasts:
The value of Mexico's pharmaceutical market reached MXN189.68bn (USD10